Eyebot Raises $20M Series A to Transform Eye Care Access

\nEyebot, the Boston-based startup behind 90-second vision test kiosks, just raised $20M in Series A funding to expand its nationwide network. Their kiosks deliver doctor-verified prescriptions in minutes—no appointments, no insurance hurdles, no delays. For BusinessHunt users, this isn’t just another funding headline—it’s a clear signal that healthtech and convenient, high-trust solutions are attracting serious investor attention.\n

\n\nOpportunities for the BusinessHunt Community\n
    \n
  • Service providers: Optical retailers, tech integrators, and healthcare consultants could partner with Eyebot to deploy kiosks or support operations.
    • \n
  • Founders & operators: Eyebot’s model demonstrates how automating traditional services with clinical oversight can scale rapidly, offering a blueprint for other health or retail tech ventures.
    • \n
  • Investors: The round shows strong VC interest in startups solving accessibility problems with tech, highlighting a potential category for funding.
    • \n
\n\nQuick Facts\n
    \n
  • Over 45,000 free vision tests already conducted; scaling toward 500,000 annually.
    • \n
  • Kiosks placed in malls, universities, pharmacies, grocery stores, and airports.
    • \n
  • Each test is reviewed by licensed eye doctors, combining speed with medical trust.
    • \n
  • Eyebot leases kiosks to retailers and brands, creating multiple revenue streams.
    • \n
\n\nWhy This Is Exciting\n

\nEyebot proves that tech-first healthcare solutions can win adoption from both providers and consumers. For BusinessHunt users, it’s a signal for market opportunities—from acquiring kiosks, offering complementary services, or even starting similar ventures in other high-friction industries.\n

\n\nInvestors Leading the Round\n

\nGeneral Catalyst, AlleyCorp, Baukunst, Village Global, Humba Venture, Ravelin, and Ubiquity Ventures.\n

\n